首页> 外文OA文献 >Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, phase 3 study

【2h】

Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, phase 3 study

机译：Abiraatorone醋酸盐的疗效和安全性在新诊断的新诊断，转移激素 - 幼苗前列腺癌中的血液患者：纬度的最终亚群分析，随机，双盲，安慰剂控制，第3期研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hiroyoshi Suzuki; Toshitaka Shin; Satoshi Fukasawa; Katsuyoshi Hashine; Sumiko Kitani; Noriyuki Ohtake; Kazuhiro Shibayama; Namphuong Tran; Suneel Mundle; Karim Fizazi; Nobuaki Matsubara;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-na?ve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study [J] . Satoshi Fukasawa, Hiroyoshi Suzuki, Kazushiro Kawaguchi, Japanese journal of clinical oncology. . 2018,第11期

机译：AbiraTerone醋酸盐加上泼尼松在新诊断，转移激素-NA've患者中的疗效和安全性：纬度，随机，双盲，安慰剂控制，第3期研究的亚组分析
2. Abiraterone acetate plus prednisone in patients with newly Croatia& diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial [J] . Fizazi Karim, NamPhuong Tran, Fein Luis, The lancet oncology . 2019,第5期

机译：AbiraTerone醋酸盐加上新克罗地亚患者泼尼松和诊断的高风险转移阉蛋白敏感前列腺癌（纬度）：随机，双盲，第3阶段试验的最终总体存活分析
3. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study [J] . Ryan Charles J., Smith Matthew R., Fizazi Karim, The lancet oncology . 2015,第2期

机译：醋酸阿比特龙加泼尼松与安慰剂加泼尼松在未接受化疗的转移性去势抵抗性前列腺癌男性患者中的应用（COU-AA-302）：一项随机，双盲，安慰剂对照的3期研究的最终总体生存分析
4. IMANI-1 TC3WP Single Drug HAART -Proof of Concept Study Pilot Study of the Safety and Efficacy of Kaletra (LPV/r) as Single Drug HAART in HIV+ ARV- Naive Patients - Interim Analysis of Subjects Completing Final 48 Week Data [C] . J.C. Gathe Jr., M. Washington, C. Mayberry International AIDS Conference . 2004

机译：Imani-1 TC3WP单药搭载概念研究试验试验研究Kaletra（LPV / R）作为艾滋病毒+ ARV天真患者单药HAART的安全性和有效性 - 临时分析受试者完成最终的48周数据
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE a randomized double-blind placebo-controlled phase 3 study [O] . Hiroyoshi Suzuki, Toshitaka Shin, Satoshi Fukasawa, -1

机译：醋酸阿比特龙+泼尼松对日本初诊转移性激素初治前列腺癌患者的疗效和安全性：LATITUDE的最终亚组分析一项随机双盲安慰剂对照的3期研究
7. Benefit Of Abiraterone Acetate Plus Prednisone (AA+P) Added To Androgen Deprivation Therapy (ADT) In Patients With High-Risk, Newly Diagnosed Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): Post Hoc Analysis Of EQ-5D-5L From The Latitude Study [O] . H Metin, K McQuarrie, P Thilakarathne, 2018

机译：AbiraTerone醋酸盐加上泼尼松（AA + P）的益处加入雄激素剥夺治疗（ADT）的高风险，新诊断的转移激素敏感前列腺癌（MHSPC）：从纬度的EQ-5D-5L后的HOC分析学习

Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, phase 3 study

著录项

引文网络

相似文献

相关主题

期刊订阅